Cliquer sur une vignette pour aller sur Google Books.
Chargement... Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995 (édition 1995)par Louis Galambos (Auteur), Jane Eliot Sewell (Contributeur)
Information sur l'oeuvreNetworks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995 par Louis Galambos
Aucun Chargement...
Inscrivez-vous à LibraryThing pour découvrir si vous aimerez ce livre Actuellement, il n'y a pas de discussions au sujet de ce livre. Aucune critique aucune critique | ajouter une critique
Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals. Aucune description trouvée dans une bibliothèque |
Discussion en coursAucun
Google Books — Chargement... GenresClassification décimale de Melvil (CDD)615.372Technology Medicine and health Pharmacology and therapeutics Organic drugs SerotherapyClassification de la Bibliothèque du CongrèsÉvaluationMoyenne: Pas d'évaluation.Est-ce vous ?Devenez un(e) auteur LibraryThing. |